Intralesional injections of metronidazole versus meglumine antimoniate for the treatment of cutaneous leishmaniasis

Mohammad Ali Mapar; Mohammad Omidian

Jundishapur Journal of Microbiology

Ahvaz Jundishapur University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Contact Us Support

APC

Authors Guide Submit Manuscript

Intralesional injections of metronidazole versus meglumine antimoniate for the treatment of cutaneous leishmaniasis

Author(s):

Mohammad Ali Mapar^1,*,

Mohammad Omidian²,

1Department of Dermatology, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, mapar_m@yahoo.com, Iran

2Department of Dermatology, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Iran

Jundishapur Journal of Microbiology:Vol. 3, issue 2; 79-83

Article type:Research Article

Received:Jan 01, 2010

Accepted:Apr 01, 2010

How to Cite:Mohammad Ali MaparMohammad Omidian Intralesional injections of metronidazole versus meglumine antimoniate for the treatment of cutaneous leishmaniasis.Jundishapur J Microbiol.3(2):79-83.

Abstract

Introduction and objective: Oral metronidazole is reported before as effective treatment of cutaneous leishmaniasis. The aim of the present study was to evaluate the efficacy of intralesional metronidazole injection versus intralesional meglumine antimoniate (Glucantim^®) in the treatment of cutaneous leishmaniasis.

Materials and methods: The 36 patients with clinical and parasitologic diagnosis of cutaneous leishmaniasis participated in this study. The patients were randomly divided into two groups. Group one, 18 patients were treated with weekly intralesional of Glucantiminjections, and group two, 18 patients were treated with weekly intralesional injections of metronidazole. Intralesional injections was administered enough to blanch the lesions surfaces (0.5-2ml for each lesion in both groups).

Results: Twenty eight patients completed the study. Sixteen patients in group one and 12 patients in group two. In group one, 13 patients recovered with eight injections (81%). and of group two, only three patients recovered with eight injections (16.6%). The pain of intralesional injections of metronidazole was much more than the Glucantim injections.

Conclusions: Intralesional metronidazole injections have little effect for the treatment of cutaneous leishmaniasis.

Keywords

Cutaneous leishmaniasis

Meglumine antimoniate

Glucantim

Metronidazole

Full Text

Full text is available in PDF

comments